← Back to Search

ATI-V Program for Preventing Adolescent Vaping

N/A

Waitlist Available

Research Sponsored by University of Rochester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

current 8th grade student of study school at start of school participation

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 28 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will test the effectiveness of a school-based intervention to reduce adolescent vaping. The intervention will train 8th-9th grade student peer leaders to deliver school-wide vaping prevention campaigns with ongoing adult mentoring.

Who is the study for?

This trial is for current 8th grade students in a participating school, regardless of race, color, national origin, sexual orientation, sex, gender identity, age or ability. Non-English speaking students cannot participate.

What is being tested?

The study tests the 'Above the Influence-Vaping' (ATI-V) program where trained student peer leaders run anti-vaping campaigns with adult guidance to see if it can reduce vaping among adolescents.

What are the potential side effects?

Since this intervention involves educational and social activities rather than medical treatments or drugs, there are no direct physical side effects associated with ATI-V.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am currently an 8th grader at the study school.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 28 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~28 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of participants with any past 30 day any vaping

Number of participants with any past 30 day nicotine vaping

Secondary study objectives

Mean Electronic Vaping Product Attitudes

Score Electronic Vaping Product Harm

Total Number of Trusted Adults

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Immediate Above the Influence-Vaping InterventionExperimental Treatment1 Intervention

School receives Above the Influence-Vaping (ATI-V) prevention program training after baseline assessment. Training and intervention continue over two school years (approximately 18 months). Surveys at baseline, 8 months (end 8th grade), 20 mo (end 9th grade), 28 mo (mid-10th grade).

Group II: Delayed Above the Influence-Vaping InterventionActive Control1 Intervention

Surveys at baseline, 8 months (end 8th grade), 20 mo (end 9th grade), 28 mo (mid-10th grade). ATI-V prevention program training after 4th assessment - after 28 months.

0 / 1Eligibility criteria met